Fig. 2
From: A canine-derived chimeric antibody with high neutralizing activity against canine parvovirus-2

The design of the therapeutic efficacy study of 11D9 in beagles
From: A canine-derived chimeric antibody with high neutralizing activity against canine parvovirus-2
The design of the therapeutic efficacy study of 11D9 in beagles